Published in Clin Microbiol Infect on June 14, 2014
The Association of Panton-Valentine leukocidin and mecA Genes in Methicillin-Resistant Staphylococcus aureus Isolates From Patients Referred to Educational Hospitals in Ahvaz, Iran. Jundishapur J Microbiol (2015) 0.77
First report of Panton-Valentine leukocidin-positive methicillin-susceptible Staphylococcus aureus ST88 harbouring ΦSa2usa isolated from refractory breast abscesses in Japan. New Microbes New Infect (2016) 0.75
Acquisition of virulence factors in livestock-associated MRSA: Lysogenic conversion of CC398 strains by virulence gene-containing phages. Sci Rep (2017) 0.75
Typing of Panton-Valentine Leukocidin-Encoding Phages and lukSF-PV Gene Sequence Variation in Staphylococcus aureus from China. Front Microbiol (2016) 0.75
Mutants of pertussis toxin suitable for vaccine development. Science (1989) 2.89
Norfloxacin (MK-0366) treatment of urinary tract infections in hospitalized patients. J Antimicrob Chemother (1983) 2.42
Bacteremia due to Stenotrophomonas maltophilia in patients with hematologic malignancies. Clin Infect Dis (2000) 2.40
Macrolide efflux genes mef(A) and mef(E) are carried by different genetic elements in Streptococcus pneumoniae. J Clin Microbiol (2002) 2.23
Epidemic diffusion of KPC carbapenemase-producing Klebsiella pneumoniae in Italy: results of the first countrywide survey, 15 May to 30 June 2011. Euro Surveill (2013) 2.02
The capsular polysaccharide of Bacteroides fragilis comprises two ionically linked polysaccharides. J Biol Chem (1992) 2.00
Is videopupillography useful in the diagnosis of Alzheimer's disease? Neurology (1998) 1.87
Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol (1983) 1.82
Molecular variants of human papillomavirus type 16 from four continents suggest ancient pandemic spread of the virus and its coevolution with humankind. J Virol (1992) 1.80
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature (1984) 1.71
Use of voriconazole in treatment of Scedosporium apiospermum infection: case report. J Clin Microbiol (1998) 1.63
Colistin resistance superimposed to endemic carbapenem-resistant Klebsiella pneumoniae: a rapidly evolving problem in Italy, November 2013 to April 2014. Euro Surveill (2014) 1.61
Protection from apoptotic cell death by interleukin-4 is increased in previously treated chronic lymphocytic leukemia patients. Leuk Res (1997) 1.48
Rising incidence of Candida parapsilosis fungemia in patients with hematologic malignancies: clinical aspects, predisposing factors, and differential pathogenicity of the causative strains. Clin Infect Dis (1996) 1.48
Enterococcus spp. produces slime and survives in rat peritoneal macrophages. Med Microbiol Immunol (2001) 1.47
Design and methods of the Ludwig-McGill longitudinal study of the natural history of human papillomavirus infection and cervical neoplasia in Brazil. Ludwig-McGill Study Group. Rev Panam Salud Publica (1999) 1.46
Perioperative antibiotic prophylaxis in adults. Outline of the principal recommendations. National reference guidelines. Minerva Anestesiol (2009) 1.45
Monoclonal antibody to single-stranded DNA is a specific and sensitive cellular marker of apoptosis. Exp Cell Res (1996) 1.45
Non-cemented total hip replacement for metastatic disease. Orthopedics (1993) 1.39
Analysis of a capsular polysaccharide biosynthesis locus of Bacteroides fragilis. Infect Immun (1999) 1.38
Entry pathway of vesicular stomatitis virus into different host cells. J Gen Virol (1987) 1.31
A short synthetic peptide fragment of human interleukin 1 with immunostimulatory but not inflammatory activity. J Immunol (1986) 1.30
IgA-driven T cell-mediated anti-bacterial immunity in man after live oral Ty 21a vaccine. J Immunol (1986) 1.30
Virulence factors of lactose-negative Escherichia coli strains isolated from children with diarrhea in Somalia. J Clin Microbiol (1988) 1.29
Iron availability influences aggregation, biofilm, adhesion and invasion of Pseudomonas aeruginosa and Burkholderia cenocepacia. Int J Immunopathol Pharmacol (2006) 1.28
Genetic diversity of the capsular polysaccharide C biosynthesis region of Bacteroides fragilis. Infect Immun (2000) 1.27
CMY-13, a novel inducible cephalosporinase encoded by an Escherichia coli plasmid. Antimicrob Agents Chemother (2004) 1.26
Discriminative and predictive power of an informant report in mild cognitive impairment. J Neurol Neurosurg Psychiatry (2006) 1.25
IgA-dependent cell-mediated activity against enteropathogenic bacteria: distribution, specificity, and characterization of the effector cells. J Immunol (1984) 1.24
Expanding drug resistance through integron acquisition by IncFI plasmids of Salmonella enterica Typhimurium. Emerg Infect Dis (2001) 1.22
In vivo immunostimulating activity of the 163-171 peptide of human IL-1 beta. J Immunol (1987) 1.16
Natural anti-bacterial activity against Salmonella typhi by human T4+ lymphocytes armed with IgA antibodies. J Immunol (1985) 1.16
Expression of nitric oxide synthase in ulcerative colitis. Eur J Clin Invest (1996) 1.15
Cellular immunity against Salmonella typhi after live oral vaccine. Clin Exp Immunol (1985) 1.15
Decrease of vancomycin-resistant enterococci in poultry meat after avoparcin ban. Lancet (1999) 1.14
Increased expression of periplasmic Cu,Zn superoxide dismutase enhances survival of Escherichia coli invasive strains within nonphagocytic cells. Infect Immun (2000) 1.12
The effects of inhibitors of vacuolar acidification on the release of Listeria monocytogenes from phagosomes of Caco-2 cells. J Med Microbiol (1996) 1.09
PRINTO/PRES international website for families of children with rheumatic diseases: www.pediatric-rheumatology.printo.it. Ann Rheum Dis (2005) 1.09
Comparison of multidrug resistance gene regions between two geographically unrelated Salmonella serotypes. J Antimicrob Chemother (2005) 1.08
Stabilization of glucose-6-phosphatase activity by a 21 000-dalton hepatic microsomal protein. Biochem J (1985) 1.05
In vitro generated mast cells express natural cytotoxicity against tumour cells. Immunology (1985) 1.05
Alpha interferon inhibits human herpesvirus 8 (HHV-8) reactivation in primary effusion lymphoma cells and reduces HHV-8 load in cultured peripheral blood mononuclear cells. J Virol (1999) 1.04
Prevalence, determinants, and molecular epidemiology of Streptococcus pneumoniae isolates colonizing the nasopharynx of healthy children in Rome. Eur J Clin Microbiol Infect Dis (2002) 1.03
The geographic relationship between the use of antimicrobial drugs and the pattern of resistance for Streptococcus pneumoniae in Italy. Eur J Clin Pharmacol (2004) 1.03
A monoclonal antibody to the IL-1 beta peptide 163-171 blocks adjuvanticity but not pyrogenicity of IL-1 beta in vivo. J Immunol (1989) 1.02
Involvement of gangliosides in rabies virus infection. J Gen Virol (1986) 1.01
Pathogenesis of postantibiotic diarrhoea caused by Clostridium difficile: an in vitro study in the rabbit intestine. Gut (1988) 1.00
Differential activity of interleukin 1 alpha and interleukin 1 beta in the stimulation of the immune response in vivo. Eur J Immunol (1990) 1.00
Mechanism of rabies virus entry into CER cells. J Gen Virol (1984) 0.99
Evidence for cross-infection in an outbreak of Clostridium difficile-associated diarrhoea in a surgical unit. J Med Microbiol (1988) 0.99
Receptors for BK virus on human erythrocytes. Acta Virol (1981) 0.98
Detection and characterization of vancomycin-resistant enterococci in farm animals and raw meat products in Italy. Microb Drug Resist (2000) 0.97
Mechanism of astrovirus entry into Graham 293 cells. J Med Virol (1992) 0.97
Variant esp gene in vancomycin-sensitive Enterococcus faecium. Lancet (2001) 0.96
Combined endoscopic approach in the treatment of benign broncho-oesophageal fistula. Thorax (2008) 0.96
Acid tolerance in Listeria monocytogenes influences invasiveness of enterocyte-like cells and macrophage-like cells. Microb Pathog (2000) 0.96
[Human papillomavirus associated with uterine cervix lesions]. Rev Soc Bras Med Trop (1999) 0.96
Outbreak of skin and soft tissue infections in a hospital newborn nursery in Italy due to community-acquired meticillin-resistant Staphylococcus aureus USA300 clone. J Hosp Infect (2012) 0.96
Molecular characterization of virulence determinants of Stenotrophomonas maltophilia strains isolated from patients affected by cystic fibrosis. Int J Immunopathol Pharmacol (2007) 0.96
Herpes simplex virus 2 causes apoptotic infection in monocytoid cells. Cell Death Differ (1997) 0.96
In vitro activity of fluconazole and voriconazole against isolates of Candida albicans from patients with haematological malignancies. J Antimicrob Chemother (2000) 0.95
Calmodulin-like protein from Bacillus subtilis. Biochem Biophys Res Commun (1986) 0.95
Cytotoxin and enterotoxin production by Clostridium difficile. Microbiologica (1984) 0.94
Empathy training to improve physician-patient communication skills. Acad Med (1995) 0.94
Effect of iron limitation on slime production by Staphylococcus aureus. Eur J Clin Microbiol Infect Dis (2001) 0.94
Susceptibility and genetic relatedness of invasive Haemophilus influenzae type b in Italy. Microb Drug Resist (1998) 0.94
Interferon decreases production of hydrogen peroxide by macrophages: correlation with reduction of suppressive capacity and of anti-microbial activity. Immunology (1983) 0.93
In vivo stimulation and restoration of the immune response by the noninflammatory fragment 163-171 of human interleukin 1 beta. J Exp Med (1988) 0.93
Virulence and drug susceptibility of Mycobacterium celatum. Microbiology (2000) 0.93
Carbapenem non-susceptible Klebsiella pneumoniae from Micronet network hospitals, Italy, 2009 to 2012. Euro Surveill (2012) 0.92
Purification and characterization of an immunodominant 36 kDa antigen present on the cell surface of Clostridium difficile. Microb Pathog (1992) 0.92
Effects on oral and intestinal microfloras of norfloxacin and pefloxacin for selective decontamination in bone marrow transplant patients. Antimicrob Agents Chemother (1989) 0.92
DNA microarray-based characterisation of Panton-Valentine leukocidin-positive community-acquired methicillin-resistant Staphylococcus aureus from Italy. Eur J Clin Microbiol Infect Dis (2011) 0.92
Genetic control of in vitro natural cell-mediated activity against Salmonella typhimurium by intestinal and splenic lymphoid cells in mice. Clin Exp Immunol (1984) 0.92
The alleles of the bft gene are distributed differently among enterotoxigenic Bacteroides fragilis strains from human sources and can be present in double copies. J Clin Microbiol (2000) 0.91
Cytokine gene therapy of gliomas: effective induction of therapeutic immunity to intracranial tumors by peripheral immunization with interleukin-4 transduced glioma cells. Gene Ther (2001) 0.91
Role of phospholipids in rhabdovirus attachment to CER cells. Brief report. Arch Virol (1984) 0.91
Diarrhoea associated with toxigenic Clostridium spiroforme. J Infect (1986) 0.91
Poliovirus infection induces apoptosis in CaCo-2 cells. J Med Virol (1999) 0.90
Antirotaviral activity of milk proteins: lactoferrin prevents rotavirus infection in the enterocyte-like cell line HT-29. Med Microbiol Immunol (1997) 0.89
Cell surface CD28 levels define four CD4+ T cell subsets: abnormal expression in rheumatoid arthritis. Clin Immunol (2001) 0.89
Aortic valve replacement through a minimally invasive approach. Tex Heart Inst J (1997) 0.89
Detection of Bacteroides fragilis enterotoxin in the feces of a child with diarrhea. Clin Infect Dis (1994) 0.89
Comparative analysis of immunological responses to oral (Ty21a) and parenteral (TAB) typhoid vaccines. Infect Immun (1988) 0.89
Human papillomavirus DNA and p53 status in penile carcinomas. Int J Cancer (1998) 0.89
4-Oxystilbene compounds are selective ligands for neuronal nicotinic alphaBungarotoxin receptors. Br J Pharmacol (1998) 0.89
Effects of a synbiotic milk product on human intestinal ecosystem. J Appl Microbiol (2007) 0.88
Infection of human enterocyte-like cells with rotavirus enhances invasiveness of Yersinia enterocolitica and Y. pseudotuberculosis. J Med Microbiol (2000) 0.88
New advances in anti-HSV chemotherapy. Curr Med Chem (2008) 0.88